Blood Cancer Discovery

Blood Cancer Discovery
影响因子:
11.5
ISSN:
print: 2643-3230
on-line: 2643-3249
研究领域:
Multiple-
自引率:
1.80%
Gold OA文章占比:
35.48%
原创研究文献占比:
96.88%
SCI收录类型:
Emerging Sources Citation Index (ESCI)
期刊介绍英文:
The journal Blood Cancer Discovery publishes high-quality Research Articles and Briefs that focus on major advances in basic, translational, and clinical research of leukemia, lymphoma, myeloma, and associated diseases. The topics covered include molecular and cellular features of pathogenesis, therapy response and relapse, transcriptional circuits, stem cells, differentiation, microenvironment, metabolism, immunity, mutagenesis, and clonal evolution. These subjects are investigated in both animal disease models and high-dimensional clinical data landscapes. The journal also welcomes submissions on new pharmacological, biological, and living cell therapies, as well as new diagnostic tools. They are interested in prognostic, diagnostic, and pharmacodynamic biomarkers, and computational and machine learning approaches to personalized medicine. The scope of submissions ranges from preclinical proof of concept to clinical trials and real-world evidence. Blood Cancer Discovery serves as a forum for diverse ideas that shape future research directions in hematooncology. In addition to Research Articles and Briefs, the journal also publishes Reviews, Perspectives, and Commentaries on topics of broad interest in the field.
期刊介绍中文:
《Blood Cancer Discovery》是美国癌症研究学会(AACR)于2020年创立的新刊物。期刊发布高质量的研究论文和简报,着重关注白血病、淋巴瘤、骨髓瘤等相关疾病的基础、转化和临床研究的重大进展。其涵盖的主题包括疾病发病机制的分子和细胞特征、治疗反应和复发、转录调控、干细胞、分化、微环境、代谢、免疫、诱变和克隆进化等方面。这些研究主题在动物模型和临床数据等高维数据领域得到深入探讨。 此外,该期刊鼓励提交新的药理学、生物学和活细胞治疗方法,以及新的诊断工具。他们对预后、诊断、药效生物标志物以及个性化医疗中的计算和机器学习方法也表现出浓厚兴趣。投稿范围从临床前概念验证到临床试验和实际应用等各个阶段。 《Blood Cancer Discovery》是一个讨论塑造血液肿瘤学未来研究方向的平台。除了研究论文和简报外,该期刊还发表了有关该领域其他感兴趣主题的评论、观点和评论文章。
CiteScore:
CiteScoreSJRSNIPCiteScore排名
12.74.6401.527
学科
排名
百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Biochemistry, Genetics and Molecular Biology (miscellaneous)
4 / 103
96%
大类:Medicine
小类:Oncology
41 / 404
89%
大类:Medicine
小类:Hematology
15 / 137
89%
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
34 / 230
85%
发文信息
WOS期刊分区
学科分类
Q1HEMATOLOGY
Q1ONCOLOGY
历年影响因子
2022年11.2000
2023年11.5000
历年发表
2020年56
2021年73
2022年139

Blood Cancer Discovery - 最新文献

Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations.

Pub Date : 2024-11-01 DOI: 10.1158/2643-3230.BCD-23-0138 Livius Penter, Nicoletta Cieri, Katie Maurer, Marwan Kwok, Haoxiang Lyu, Wesley S Lu, Giacomo Oliveira, Satyen H Gohil, Ignaty Leshchiner, Caleb A Lareau, Leif S Ludwig, Donna S Neuberg, Haesook T Kim, Shuqiang Li, Lars Bullinger, Jerome Ritz, Gad Getz, Jacqueline S Garcia, Robert J Soiffer, Kenneth J Livak, Catherine J Wu

T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of Treatment.

Pub Date : 2024-11-01 DOI: 10.1158/2643-3230.BCD-24-0124 Niels W C J van de Donk, Leo Rasche, Surbhi Sidana, Sonja Zweegman, Alfred L Garfall

A Role for Germline Variants in Multiple Myeloma?

Pub Date : 2024-11-01 DOI: 10.1158/2643-3230.BCD-24-0226 Brian A Walker
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信